Results 1 to 10 of about 2,053,658 (355)

Differential Antibody Response to Inactivated COVID-19 Vaccines in Healthy Subjects

Frontiers in Cellular and Infection Microbiology, 2021
The appearance and magnitude of the immune response and the related factors correlated with SARS-CoV-2 vaccination need to be defined. Here, we enrolled a prospective cohort of 52 participants who received two doses of inactivated vaccines (BBIBP-CorV ...
Jiaqi Zhang, Jiaqi Zhang, Shan Xing, Dan Liang, Wei Hu, Changwen Ke, Jinyong He, Runyu Yuan, Yile Huang, Yizhe Li, Dongdong Liu, Xuedong Zhang, Lin Li, Jianhua Lin, Weili Li, Xiangyun Teng, Yijun Liu, Wei Wen, Qiang Kang, Dawei Wang, Wanli Liu, Jianhua Xu   +21 more
doaj   +1 more source

Durability of Humoral Immune Responses to SARS-CoV-2 in Citizens of Ariano Irpino (Campania, Italy): A Longitudinal Observational Study With an 11.5-Month Follow-Up

Frontiers in Public Health, 2021
As of November 17, 2021, SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus 2), the causative agent of COVID-19 (COronaVIrus Disease 19), has infected ~250 million people worldwide, causing around five million deaths.
Annachiara Coppola, Annachiara Coppola, Carlo Buonerba, Davide Cardinale, Gabriella Lo Conte, Donato Sansone, Giuseppe Rofrano, Sabato De Vita, Maria Morgante, Maria Triassi, Luigi Atripaldi, Gianfranco Brambilla, Rocco Sabatino, Rocco Sabatino, Andrea Pierri, Daniela Pacella, Antonio Pizzolante, Biancamaria Pierri, Veronica Ferrucci, Massimo Zollo, Mario Capasso, Silvia Stringhini, Paolo Antonio Ascierto, Sante Roperto, Pellegrino Cerino   +24 more
doaj   +1 more source

Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-19 antigens? [PDF]

Iranian Journal of Immunology, 2021
Background: Incidence and severity of SARS-CoV2 infection are significantly lower in children and teenagers proposing that certain vaccines, routinely administered to neonates and children may provide cross-protection against this emerging infection ...
Danesh Hassani, Mohammad Mehdi Amiri, Faezeh Maghsood, Vahid Salimi, Gholam Ali Kardar, Omid Barati, Seyed Mohammad Reza Hashemian, Mahmood Jeddi-Tehrani, Amir-Hassan Zarnani, Fazel Shokri   +9 more
doaj   +1 more source

Prevalence of COVID-19 Virus Infection in Semnan province [PDF]

Iranian Journal of Immunology, 2021
Background: Severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) causing a human pandemic disease named COVID-19 has become a major global health concern.
Elahe Jandaghi, Maral Hemati, Maryam Mohammadlou, Jafar Jandaghi, Majid Mirmohammadkhani, Navid Danaei, Parviz Kokhaei   +6 more
doaj   +1 more source

Vaccine Type-, Age- and Past Infection-Dependence of the Humoral Response to SARS-CoV-2 Spike S Protein

Frontiers in Immunology, 2022
The emergence of COVID-19 has led to a worldwide challenge for the rapid development of vaccines. Several types of safe and effective vaccines have been available in a time frame never seen before.
Salvador Romero-Pinedo, Marina Quesada, Lydia Horndler, Stela Álvarez-Fernández, Asunción Olmo, David Abia, Balbino Alarcón, Pilar Delgado   +7 more
doaj   +1 more source

Short-Term Humoral Immune Response of the pcDNA4-G Plasmid Expressing the Bovine Ephemeral Fever Virus G Gene in BALB/c Mice

Veterinaria Italiana, 2021
Bovine ephemeral fever (BEF) is an arthropod‑borne viral disease characterised by a short‑term clinical expression that can lead to significant losses in high‑yielding cattle and water buffaloes.
Hasan Abayli, Hakan Bulut
doaj   +1 more source

Transgenerational Effects of Maternal Immune Activation on Specific Antibody Responses in Layer Chickens

Frontiers in Veterinary Science, 2022
Activation of the maternal immune system may affect innate and adaptive immune responses in the next generation and may therefore have implications for vaccine efficacy and dietary immune modulation by feed additives.
Michel B. Verwoolde, Michel B. Verwoolde, Joop Arts, Christine A. Jansen, Henk K. Parmentier, Aart Lammers   +5 more
doaj   +1 more source

The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients

Frontiers in Immunology, 2021
Increasing evidence suggests that dysregulated immune responses are associated with the clinical outcome of coronavirus disease 2019 (COVID-19). Nucleocapsid protein (NP)-, spike (S)-, receptor binding domain (RBD)- specific immunoglobulin (Ig) isotypes,
Huanle Luo, Huanle Luo, Tingting Jia, Jiamin Chen, Shike Zeng, Zengzhao Qiu, Shu Wu, Xu Li, Yuxuan Lei, Xin Wang, Weihua Wu, Renli Zhang, Xuan Zou, Tiejian Feng, Ruxia Ding, Yue Zhang, Yao-Qing Chen, Yao-Qing Chen, Caijun Sun, Caijun Sun, Tian Wang, Tian Wang, Tian Wang, Shisong Fang, Yuelong Shu, Yuelong Shu   +25 more
doaj   +1 more source

Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients – the Vienna Cohort

Frontiers in Immunology, 2021
BackgroundDialysis patients are at high risk for a severe clinical course after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Georg Beilhack, Rossella Monteforte, Florian Frommlet, Martina Gaggl, Robert Strassl, Andreas Vychytil   +5 more
doaj   +1 more source

Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays

GMS Infectious Diseases, 2020
Commercially available immunoassays have been developed for sensitive and specific detection of antibodies against SARS-CoV-2. While high sensitivity has been reported in hospitalized COVID-19 patients, little is known about the performance of the assays
Wellinghausen, Nele, Voss, Meike, Ivanova, Ralitsa, Deininger, Susanne   +3 more
doaj   +1 more source